MedTec: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedTec
Largest movements
- Cash -€2,635
down €2,635 (-32.6%), from €8,083 to €5,448
mainly Other debts (-€10,228) and Investment in fixed assets (net) (-€346)
- Intangible fixed assets -€715
down €715 (-44.7%), from €1,597 to €882
- Other debts -€10,228
no longer reported in 2025 (was €10,228)
- Profit (loss) carried forward +€6,955
up €6,955 (+22.8%), from -€30,548 to -€23,594
- Gross operating margin +€10,368
up €10,368, from -€1,479 to €8,888
- Depreciation -€2,334
down €2,334 (-68.8%), from €3,395 to €1,061
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,680 | €6,406 | -€3,273 | -33.8% |
| Fixed assets | 21/28 | €1,597 | €882 | -€715 | -44.7% |
| Intangible fixed assets | 21 | €1,597 | €882 | -€715 | -44.7% |
| Current assets | 29/58 | €8,083 | €5,524 | -€2,559 | -31.7% |
| Cash at bank and in hand | 54/58 | €8,083 | €5,448 | -€2,635 | -32.6% |
| Deferred charges and accrued income | 490/1 | - | €77 | +€77 | |
| Total equity and liabilities | 10/49 | €9,680 | €6,406 | -€3,273 | -33.8% |
| Equity | 10/15 | -€548 | €6,406 | +€6,955 | |
| Contributions | 10/11 | €30,000 | €30,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€30,548 | -€23,594 | +€6,955 | +22.8% |
| Amounts payable | 17/49 | €10,228 | - | -€10,228 | |
| Amounts payable within one year | 42/48 | €10,228 | - | -€10,228 | |
| Other amounts payable | 47/48 | €10,228 | - | -€10,228 | |
| Non-recurring operating income | 76A | - | €10,228 | +€10,228 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,395 | €1,061 | -€2,334 | -68.8% |
| Other operating charges | 640/8 | €878 | €823 | -€55 | -6.2% |
| Gross operating margin | 9900 | -€1,479 | €8,888 | +€10,368 | |
| Operating profit (loss) | 9901 | -€5,752 | €7,005 | +€12,756 | |
| Financial charges | 65/66B | €69 | €50 | -€19 | -27.0% |
| Recurring financial charges | 65 | €69 | €50 | -€19 | -27.0% |
| Profit (loss) for the period before taxes | 9903 | -€5,820 | €6,955 | +€12,775 | |
| Profit (loss) for the period | 9904 | -€5,820 | €6,955 | +€12,775 | |
| Profit (loss) for the period to be appropriated | 9905 | -€5,820 | €6,955 | +€12,775 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.